Search results
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Short Interest Update
ETF DAILY NEWS· 3 days agoOutlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 1,660,000 ...
Melatonin may stave off age-related vision loss, study hints
Live Science via Yahoo News· 6 days agoA large new analysis has tied the use of supplemental melatonin to a lower risk of developing one of...
Cantor Fitzgerald Reaffirms Overweight Rating for Skye Bioscience (NASDAQ:SKYE)
ETF DAILY NEWS· 1 day agoCantor Fitzgerald restated their overweight rating on shares of Skye Bioscience (NASDAQ:SKYE – Free...
Professional Faqs: How Long Is Infectious Mononucleosis Contagious?
MSN News· 6 days agoExpert opinion from Ramamurthy Bangalore M.D., F.C.C.P., F.A.C.P., F.A.A.S.M. (Pulmonologist) · 30...
Drug approved as sickle cell disease treatment may help stabilize vision in rare genetic disease
Medical Xpress· 3 days agoLouis have dedicated many years to understanding the rare condition known as retinal vasculopathy...
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com NG
Investing.com· 6 days agoShares Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
Cantor Fitzgerald Comments on Skye Bioscience, Inc.’s FY2024 Earnings (NASDAQ:SKYE)
ETF DAILY NEWS· 4 days agoSkye Bioscience, Inc. (NASDAQ:SKYE – Free Report) – Investment analysts at Cantor Fitzgerald raised their FY2024 earnings per share estimates for shares of Skye Bioscience in a research report ...
REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 11 hours agoShares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat.com reports ...
Roche, local startup Ascidian sign $1.8B deal for neurological medicines - Boston Business Journal
The Business Journals· 2 days agoAscidian Therapeutics has signed a deal with Roche in the Boston startup’s first-ever partnership....
Tackling blindness with focus on vision
China Daily· 3 days ago"I never expected to not only have my eyes saved, but also continue to save lives in the operating room," said an anesthesiologist surnamed Cheng in Chongqing municipality. After being diagnosed ...